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Abstract: Metabolic inhibition is a common condition observed during ischemic heart disease and
heart failure. It is usually accompanied by a reduction in L-type Ca2+ channel (LTCC) activity. In this
study, however, we show that metabolic inhibition results in a biphasic effect on LTCC current (ICaL)
in human and rat cardiac myocytes: an initial increase of ICaL is observed in the early phase of
metabolic inhibition which is followed by the more classical and strong inhibition. We studied the
mechanism of the initial increase of ICaL in cardiac myocytes during β-adrenergic stimulation by
isoprenaline, a non-selective agonist of β-adrenergic receptors. The whole-cell patch–clamp technique
was used to record the ICaL in single cardiac myocytes. The initial increase of ICaL was induced by a
wide range of metabolic inhibitors (FCCP, 2,4-DNP, rotenone, antimycin A). In rat cardiomyocytes,
the initial increase of ICaL was eliminated when the cells were pre-treated with thapsigargin leading
to the depletion of Ca2+ from the sarcoplasmic reticulum (SR). Similar results were obtained when
Ca2+ release from the SR was blocked with ryanodine. These data suggest that the increase of ICaL in
the early phase of metabolic inhibition is due to a reduced calcium dependent inactivation (CDI) of
LTCCs. This was further confirmed in human atrial myocytes where FCCP failed to induce the initial
stimulation of ICaL when Ca2+ was replaced by Ba2+, eliminating CDI of LTCCs. We conclude that
the initial increase in ICaL observed during the metabolic inhibition in human and rat cardiomyocytes
is a consequence of an acute reduction of Ca2+ release from SR resulting in reduced CDI of LTCCs.
Keywords: L-type Ca2+ current; metabolic inhibition; FCCP; heart; cardiac myocytes; sarcoplasmic
reticulum; calcium dependent inactivation
1. Introduction
The L-type Ca2+ channels (LTCCs) provide Ca2+ for the initiation and regulation of cell contraction
and thus play a main role in cardiac muscle contraction. During normal cardiac excitation–contraction
coupling, a relatively small amount of Ca2+ enters the cell via the L-type current (ICaL) and this
triggers the release of a larger amount of Ca2+ from the sarcoplasmic reticulum (SR) via ryanodine
receptors (RyRs) in a process called Ca2+-induced Ca2+ release [1]. The increase of intracellular Ca2+
concentration in the vicinity of closely associated Ca2+ channels and RyRs leads to calcium dependent
inactivation (CDI) of LTCCs [2] and reduction of ICaL [3]. Hence, the SR participates in regulation
of the activity of plasmalemmal L-type Ca2+ channels [4]. The close functional interaction between
plasmalemma and SR means that LTCCs and RyRs can change the activity of each other and alter the
balance of cellular Ca2+, which directly activates the contraction of myofilaments. The mechanisms
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of Ca2+ regulation in diseased cardiac cells may be disordered. Malfunction of LTTCs and RyRs
interaction may affect the contractility of myocardium and, as a consequence, the main function of the
heart, to pump blood, may be altered.
Metabolic inhibition is commonly observed during ischemic heart disease and heart failure
and is associated with biphasic changes in action potential (AP) duration in heart cells and whole
heart [5,6]. Numerous studies show a reduction in cardiac LTCC activity and ICaL during metabolic
inhibition, however the mechanisms involved are not clear [7–11]. In ischemic heart failure, the cardiac
β-adrenergic receptors are downregulated, partly because of the decreased number of the receptors
and partly because of internalization and desensitization of the receptors, however also because the
sympathetic system is activated and the level of catecholamines is increased [12,13]. Thus, we decided
to investigate the effect of metabolic inhibition on ICaL during β-adrenergic stimulation in human
atrial and ventricular myocytes and rat ventricular myocytes. Surprisingly, we found that metabolic
inhibition causes an acute transient increase of ICaL amplitude followed by a rapid reduction. This is
consistent with the most recent study demonstrating AP prolongation during metabolic inhibition
in the rabbit heart [6], however is in contrast with what we reported recently in frog cardiomyocytes,
where metabolic inhibition only suppresses ICaL without the initial increase [11]. We explored the
mechanisms responsible for the initial increase in ICaL during metabolic inhibition. Our results point
to a modulation of the Ca2+-dependent inactivation of LTCCs by the RyRs mediated Ca2+ release.
2. Results
2.1. Effect of Metabolic Inhibition on ICaL in Human Atrial Myocytes
The first series of experiments were set to determine the effect of metabolic inhibition on ICaL
in human atrial myocytes. The cardiac myocytes for the first series of experiments were derived
from five patients. Metabolic inhibition was induced by the application of mitochondrial uncoupler
carbonyl cyanide-p-trifluoromethoxyphenylhydrazone (FCCP) to isoprenaline (a non-selective agonist
of β-adrenergic receptors, ISO) stimulated human atrial cells and changes of ICaL were monitored.
Surprisingly, in most of the tested human atrial cells, FCCP induced a biphasic effect on ICaL, i.e.,
a rapid initial stimulation of ICaL that was followed by a strong inhibition of ICaL.
The initial stimulation of ICaL induced by FCCP was recorded in six out of nine (~67%) tested
human atrial myocytes. In these cells, the application of 30 or 100 nmol/L of FCCP resulted in a
transient increase of ISO-stimulated ICaL by 11.4 ± 2.5% (n = 3, p < 0.05, 2 patients) and 9.0 ± 2.8%
(n = 3, p < 0.05, 2 patients), respectively. In all human atrial myocytes tested, metabolic inhibition led
to a final suppression of ICaL by 65.5 ± 5.6% (n = 5, p < 0.05, 2 patients) and 55.8 ± 9.8% (n = 4, p < 0.05,
3 patients) with 30 and 100 nmol/L FCCP, respectively (Figure 1a,b).
2.2. Effect of Metabolic Inhibition on ICaL in Human Ventricular Myocytes
The next series of experiments were set to determine the effect of metabolic inhibition on ICaL in
human ventricular myocytes. The ventricular myocytes for these series of experiments were derived
from eight patients. We performed experiments in human ventricle myocytes, applying metabolic
inhibitors FCCP and 2,4-Dinitrophenol (DNP) on ISO (1 µmol/L) stimulated cells. We found that
FCCP induced a rapid initial stimulation of ICaL in three out of six ventricular myocytes (five patients).
Further, 100 nmol/L of FCCP increased ISO-stimulated ICaL by 24.8 ± 5.3% (n = 3, p < 0.05).
The reduction of ICaL induced by FCCP was registered in all tested cells, i.e., ICaL was reduced
by 42.5 ± 3.5% (n = 6, p < 0.05). Another uncoupler, DNP, also evoked a transient increase of
ISO-stimulated ICaL in five ventricular myocytes from nine (three patients). Further, 100 µmol/L of
DNP increased ISO-stimulated ICaL by 5.0 ± 0.9% (n = 5, p < 0.05). The reduction of ICaL by 44.8 ± 4.4%
induced by DNP was registered in all (n = 9, p < 0.05) human ventricular myocytes (Figure 1c,d).
The initial stimulation of ICaL induced by uncouplers FCCP and DNP was recorded in eight out of
15 (~53%) tested human ventricular myocytes.
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2.3. Transient Increase of ICaL is Also Elicited in Rat Cardiac Myocytes
While ICaL suppression during metabolic inhibition was previously demonstrated by numerous
studies [7–10], the transient increase in ICaL amplitude during metabolic inhibition in cardiac
myocytes has not previously been reported. To determine if this phenomenon is specific to human
cardiomyocytes, we reproduced the same type of experiments in rat ventricular myocytes. Application
of FCCP (100 nmol/L) in ISO-stimulated cells induced a transient increase in ICaL by 20.2 ± 2.7%
(n = 12, p < 0.05, four animals) that was followed by ICaL reduction by 42.4 ± 4.6% (n = 12, p < 0.05)
(Figure 1e,f). Higher concentrations of FCCP like 300 nmol/L (not shown) and 1 µmol/L (Figure 1e)
also induced a biphasic effect in rat ventricular myocytes.
To confirm that the effects of uncouplers on ICaL were due to metabolic inhibition, effects of other
metabolic inhibitors were also tested. Rotenone (30 µmol/L), an inhibitor of the complex I of the
mitochondrial respiratory chain, also caused an initial increase of ISO-stimulated ICaL by 11.4 ± 0.2%
(n = 3, p < 0.05, 2 animals) and later reduced ICaL by 28.2 ± 7.6% (n = 3, p < 0.05). Antimycin A
(10 µmol/L), an inhibitor of the complex III of the mitochondrial respiratory chain, initially increased
ISO stimulated ICaL by 8.3 ± 2.3% (n = 5, p < 0.05) and decreased by 35.5 ± 1.9% (n = 5, p < 0.05,
3 animals, Figure 1f, Supplementary Figure S1). The initial transient stimulation of ICaL was recorded in
all tested rat cardiomyocytes during the early phase of metabolic inhibition regardless of the metabolic
inhibitor used. The effects of metabolic inhibitors in cardiac cells are summarized in Supplementary
Table S1.
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Figure 1. Effect of metabolic inhibition on isoprenaline stimulated ICaL in human and rat 
cardiomyocytes. (a) Effect of FCCP on isoprenaline (ISO)-stimulated ICaL in human atrial cell. Traces 
of ICaL shown in the panel were recorded at the times indicated by the corresponding letters on the 
main graph. (b) Peak amplitude of ICaL during exposure of ISO-stimulated human atrial cells to 
FCCP. (c) Effect of 2,4-Dinitrophenol (DNP) on ISO-stimulated ICaL in human ventricular cell. Traces 
of ICaL shown in the panel were recorded at the times indicated by the corresponding letters on the 
main graph. (d) Peak amplitude of ICaL during exposure of ISO-stimulated human ventricular cells to 
DNP and FCCP. (e) Effect of FCCP on ISO-stimulated ICaL in rat ventricular cells. Traces of ICaL shown 
in the panel were recorded at the times indicated by the corresponding letters on the main graph. (f) 
Peak amplitude of ISO-stimulated ICaL during exposure of rat ventricular cells to various inhibitors of 
oxidative phosphorylation. White bars in panels (b), (d) and (f) represent 100% of ISO stimulation, 
grey bars represent transient stimulation of ICaL and black bars represent suppression of ICaL during 
metabolic inhibition. Values are presented as means ± SEM for the number of cells indicated in 
parentheses. * p < 0.05 versus ISO alone. DNP – 2,4-Dinitrophenol, Rot – rotenone, Ant A – antimycin 
A. 
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2.4. Effect of Metabolic Inhibition on ICaL Kinetics
To get an insight on the possible mechanisms of ICaL increase, we analyzed the effect of metabolic
inhibition on time dependent inactivation of ICaL in ISO stimulated cells. The time dependent
inactivation of ICaL in isolated adult rat ventricular myocytes was determined by bi-exponential
fitting to the decay of current (see Methods) and by characterizing two kinetically distinct fast (ICaL,1)
and slow (ICaL,2) current components [14]. Double exponential fit to the decay phases of ICaL revealed
that during the transient increase of ICaL with FCCP (100 nmol/L) in ISO stimulated cells, the time
constant of the fast component τ1 increased from 5.3± 0.3 ms to 7.9± 1.1 ms (n = 12, p < 0.05), while the
time constant of the slow component τ2 decreased from 48.7 ± 2.9 ms to 42.6 ± 2.5 ms (n = 12, p < 0.05).
The changes in the amplitude of fast and slow components of ICaL were relatively small. During the
inhibitory phase when the effect of FCCP reached steady-state, τ1 and τ2 were 13.8 ± 2.1 ms (n = 12,
p < 0.05) and 42.7 ± 3.6 ms (n = 12), respectively, meanwhile the amplitude of both components of ICaL
were reduced. The ICaL curves are presented in Supplementary Figure S2. These data show that in
the presence of FCCP, there is a significant increase in τ1, suggesting a diminished calcium dependent
inactivation (CDI) of the channels.
We also measured the current–voltage relationship (I–V) and the steady–state inactivation of ICaL
in rat ventricular cells (Figure 2). Averaged data of ICaL I–V curves (Figure 2a and normalized data in
Figure 2b) and inactivation (Figure 2c) in control conditions, in the presence of ISO and in the presence
of ISO + FCCP, are shown. The points in the figure represent experimental recorded data and the
I–V curves were fitted to the Boltzmann equation (see Methods). Derived values for V1/2 in control,
ISO and FCCP were −13.26 ± 0.87 mV, −20.71 ± 0.81 mV and −18.80 ± 0.99 mV and k was 6.9 ± 0.4,
7.1 ± 0.6 and 6.5 ± 0.2 (n = 3), respectively. As expected, ISO significantly shifted I–V curve to the
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left [15] by > 7 mV (p < 0.05) while FCCP had no significant effect on the ICaL I–V relationship. The fit
of the steady–state inactivation curves for control, ISO and FCCP led to V1/2 values of −29.20 ± 1.15
mV, −32.05 ± 1.60 mV and −32.75 ± 1.42 mV, respectively, and k was 6.2 ± 0.1, 5.9 ± 0.3 and 5.7 ± 0.1
(n = 3), respectively. Again, ISO significantly shifted the inactivation of ICaL to the left by ≈3 mV
(p < 0.05), however the effect of FCCP was negligible. The changes of curve steepness k under the
influence of ISO or FCCP were insignificant both for I–V and for steady–state inactivation curves.
2.5. Suppression of Cytosolic Ca2+ Release Abolish Transient Increase of ICaL
The above results showed that in human and rat cardiac cells, metabolic inhibition induced initial
transient increase of ICaL. In our previous study, we found no such stimulation during metabolic
inhibition in frog cardiomyocytes [11] where SR is scarce and lacks ryanodine channels [16] and,
in contrast to mammalian cells, LTCCs do not have such a strong functional relationship with RyRs.
Consequently, we hypothesized that the observed increase of ICaL in mammalian cells may involve
metabolic sensitivity of SR and RyRs in regulation of calcium dependent inactivation (CDI) of LTCCs.
To test this hypothesis, additional experiments were performed in rat cardiomyocytes in which Ca2+
release from SR was suppressed prior to metabolic inhibition.
First, metabolic inhibition was induced after the pretreatment of myocytes with thapsigargin
(2 µmol/L). Thapsigargin inhibits SR Ca2+ ATPase (SERCA) and impairs Ca2+ uptake by the SR and
thus leads to the depletion of Ca2+ in the SR [17]. As expected, thapsigargin diminished CDI of LTCCs
which led to the increase in ISO-stimulated ICaL in rat ventricular myocytes to 142.1 ± 8.3%, i.e.,
from 17.7 ± 0.5 pA/pF to 25.1 ± 0.9 pA/pF (n = 5, p < 0.05). In the presence of thapsigargin, the initial
ICaL increase was completely eliminated and only an inhibitory effect of FCCP on ISO stimulated
ICaL was observed (n = 5, p < 0.05) (Figure 3a,b). Double exponential fit of the decay of ICaL revealed
that application of thapsigargin on ISO stimulated rat cardiac cells resulted in an increase of all ICaL
parameters. The time constants τ1 and τ2 increased from 5.5 ± 0.5 ms to 26.2 ± 2.6 ms and from
70.3 ± 4.2 ms to 88.2 ± 3.0 ms (n = 4, p < 0.05), respectively. In the presence of thapsigargin, the effect
of FCCP on τ1 was abolished. The time constant τ1 in such conditions remained similar to thapsigargin
treated cells and was 26.4 ± 0.5 ms, while τ2 was similar to ISO stimulated ICaL and was 69.1 ± 3.7 ms
(n = 4). The representative ICaL traces and their fits are shown in Figure 3c. Additionally, we used an
alternative approach to eliminate the CDI of LTCCs prior the metabolic inhibition by blocking RyR
channels with ryanodine (10 µmol/L) in rat ventricular cells. Similar to experiments with thapsigargin,
ryanodine increased ISO stimulated ICaL and the application of FCCP failed to induce the initial ICaL
increase and, thus, only an inhibition of ISO stimulated ICaL was observed (Supplementary Figure S3).
The results obtained with thapsigargin and ryanodine in rat ventricular cells point to a possible
role of CDI in the ICaL increase during the early phase of metabolic inhibition. To further confirm
this hypothesis, we measured the changes of ICaL facilitation in rat cardiac cells in the absence and
presence of FCCP. Increased frequency (to 1 Hz) of depolarization after a 20 s pause was used in
these series of experiments. The peak amplitude of ICaL and the ICaL area were compared at the time
of the first and fourth depolarizing pulse. In control conditions, increased stimulation frequency
enhanced ICaL amplitude by 8.3 ± 2.1% and the area by 46.9 ± 6.3% (n = 12, p < 0.05) during the
fourth depolarizing pulse. In ISO stimulated rat cardiac cells, increasing stimulation frequency to
1 Hz also induced ICaL facilitation and increased ICaL peak amplitude and area by 22.2 ± 5.3% and
42.0± 8.6% (n = 7, p < 0.05), respectively (Figure 4a,b). Double exponential fits of ICaL decay during the
first and fourth depolarizing pulses revealed that the time constant of the fast component τ1 increased
from 5.8 ± 0.5 ms to 7.3 ± 0.7 ms (n = 8, p < 0.01), while the time constant of the slow component
τ2 decreased from 62.1 ± 4.8 ms to 51.3 ± 2.6 ms (n = 8, p < 0.01). The ICaL curves are presented in
Supplementary Figure S4. After treatment of rat ventricular myocytes with FCCP, ICaL facilitation was
no longer observed and ICaL amplitude and area were reduced by 23.6 ± 4.1% and 23.1 ± 3.3% (n = 6,
p < 0.05, Figure 4a,b) during the fourth depolarizing pulse, respectively.
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Figure 2. Current–voltage relationship and inactivation of ICaL in rat ventricular cells.
(a) Current–voltage (I–V) relationship, (b) normalized I–V relationship. Insets on the right:
I–V measurements (representative of traces of ICaL registered during S1 in control, in ISO stimulated
cell and in the presence of FCCP). (c) Inactivation curves of ICaL under basal conditions, during ISO
(1 µmol/L) stimulation and during exposure to FCCP (100 nmol/L) in the presence of ISO in rat
ventricular cells. Inset: Double-pulse protocol used for the inactivation curves (see Methods for details).
ICaL peak amplitude during S2 pulse is expressed as a percentage of ICaL measured at 0 mV without
conditioning pulse S1 and plotted as a function of S1 pulse potential. Points represent experimentally
measured values; lines represent values calculated with Boltzmann equation. Insets below: Inactivation
of ICaL (representative traces of ICaL registered during S2 in control, in ISO stimulated cell and in the
presence of FCCP).
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at the times indicated by the corr s nding letters on the main graph. (b) Peak amplitude of ICaL during
exposur of ISO-sti ulated rat ventricular c lls to FCCP in the presence of thapsigargin. V lues are
presented as means ± SEM for the number of cells indicated in parentheses. * p < 0.05 versus ISO alone.
(c) The time depend nt inactivation of LTCCs currents. Trac s of ICaL in isopre aline (ISO, 1 µmol/L)
stimulated (black line) rat c ll during application of hapsigargin (Thapsig, 2 µmol/L) ( ed line) and
metabolic inhibition by FCCP (0.1 µ o /L) (blue line). Dashed lines represent double exponential fits
of ICaLs decay.
These data indicate that pharmacological or frequency-dependent depletion of Ca2+ from the
cytosolic Ca2+ store results in an increased τ1 and thus reduced CDI, followed by an increase
of Ca2+ influx through LTCCs, a process that is possibly observed during the early phase of
metabolic inhibition.
Depletion of Ca2+ from the SR by thapsigargin eliminated ICaL facilitation (Figure 4c) and, during
the application of ICaL facilitation protocol, the amplitude and area of ICaL measured during the fourth
depolarizing pulse were reduced by 20.0 ± 0.6% and 22.8 ± 2.4%, respectively (n = 4, p < 0.05) when
compared with the first depolarizing pulse. After the application of FCCP in ISO-stimulated and
thapsigargin treated rat cells, the ICaL frequency-dependent facilitation remained abolished and the
amplitude and area of ICaL were reduced during the fourth depolarizing pulse by 22.7 ± 1.8% and
20.0 ± 1.4%, respectively (n = 4, p < 0.05). The observation that the application of FCCP abolishes the
facilitation of ICaL in a similar manner as the depletion of Ca2+ from the SR, indicates that FCCP affects
CDI of LTCCs.
2.6. Effect of Metabolic Inhibition on Ba2+ Current (IBa) through L-Type Calcium Channels
As an alternative approach to test if reduced CDI plays a key role in the transient potentiation
of ICaL during metabolic inhibition, we performed experiments in human atrial myocytes in which
CaCl2 in the external solution was replaced by the equimolar BaCl2. LTCCs are permeable to Ba2+,
however Ba2+ ions do not induce Ca2+ release from the SR and, thus, abolish CDI of LTCCs. As shown
in Figure 5, metabolic inhibition induced only the suppression of Ba2+ current (IBa) without the
transient increase observed in ICaL. At 100 nmol/L and 1 µmol/L concentrations, FCCP suppressed
the ISO-stimulated IBa by 83.3 ± 1.6% (n = 7, p < 0.05, 3 patients) and 84.5 ± 3.5% (n = 3, p < 0.05,
2 patients), respectively (Figure 5b).
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3. Discussion
In the present study, we demonstrate that metabolic inhibition has a biphasic effect on ICaL in
mammalian cardiac myocytes. In most human atrial and ventricular myocytes and in all the tested rat
ventricular myocytes that were stimulated by isoprenaline metabolic inhibition, this induced an initial
transient increase of ICaL which was followed by a strong inhibition of ICaL. The transient increase in
ISO stimulated ICaL was induced by various metabolic inhibitors (FCCP, DNP, rotenone, antimycin
A), demonstrating that the observed effect is not dependent on the method used to induce metabolic
inhibition. In the control experiments without metabolic inhibition, we observed only run-down of the
ICaL and no spontaneous increase in ICaL was detected (Supplementary Figure S5). We propose that the
transient ICaL increase during the initial phase of metabolic inhibition is due to impaired intracellular
calcium cycling and suggest that this increase in ICaL is mediated by weak CDI due to metabolic failure
of Ca2+ release from SR via RyRs. Presumably, during metabolic inhibition, the stimulation of ICaL
and suppression of ICaL happen at the same or almost at the same time and therefore it is difficult to
discriminate between these two processes. The suppression becomes dominant during exposure to the
metabolic inhibitors and therefore makes evaluation of dose-response difficult and not reliable. In this
study, we seek to reveal the mechanism of the transient increase of ICa,L during metabolic inhibition
and did not conduct concentration–dependence experiments.
To our knowledge, ICaL stimulation by metabolic inhibitors has not been previously reported
in cardiac cells. McHugh and Beech (1996) [18] found a similar effect in single smooth muscle cells
isolated from the basilar artery of the guinea pig where the mitochondrial uncoupler 2,4-dinitrophenol
induced an initial stimulation of ICaL in some of the cells, which was followed by a pronounced
current inhibition. The authors have attributed this effect to a leftward shift of the Ca2+ channel
activation curve. In our experiments, the leftward shift in the ICaL I–V relationship was induced only
by application of ISO which is consistent with β-adrenergic stimulation [15]. However, there was no
additional shift in the ICaL I–V curve during the application of FCCP (Figure 2). Therefore, the transient
increase in ICaL during metabolic inhibition in cardiac myocytes can not be attributed to the changes in
LTCCs voltage-dependent activation.
Our recent study [11] has revealed that metabolic inhibition only exerts a strong inhibitory
effect on ICaL in amphibian heart cells without the initial transient increase observed here. In frog
cardiomyocytes, SR is scarce and lacks ryanodine channels [16]. Thus, LTCCs are the primary source
of Ca2+ for contraction in amphibian cardiomyocytes and Ca2+ release from the SR plays only a minor
role, while in mammalian hearts, the SR serves as the main Ca2+ store and plays an important role in
the regulation of the activity of LTCCs [4,19]. Therefore, we have hypothesized that impairment of Ca2+
induced Ca2+ release (CICR) leading to diminished Ca2+ dependent inactivation (CDI) of LTCCs might
underlie the transient increase in ICaL amplitude. It has previously been demonstrated that metabolic
inhibition affects properties of intracellular Ca2+ release and decreases frequency of spontaneous
Ca2+ waves [10,20]. The reports on the changes in SR Ca2+ load during metabolic inhibition are
rather inconsistent as some studies have reported no change or a decrease in SR Ca2+ content [8,21],
while others demonstrated an increase in SR Ca2+ load [20]. Such discrepancies in the results can be at
least partially explained by the reported biphasic effect of metabolic inhibition on intracellular Ca2+
signaling, consisting of an initial inhibition followed by stimulation of SR Ca2+ release [10]. The effect
of metabolic inhibition on SR may arise due to the changes in high-energy phosphate compounds
and/or the increase in intracellular acidosis. Recently, we have shown that acidosis may play a key role
in the suppression of LTCCs activity during metabolic inhibition [11]. The intracellular acidification
may also inhibit the release of Ca2+ from SR as well as the reuptake of Ca2+ to the SR by SR Ca2+
ATP-ase, the activity of which may also be inhibited by deficiency of energy compounds. During
metabolic inhibition, both Ca2+ release (RyRs) and reuptake (Ca2+ ATP-ase) mechanisms are inhibited
to a different extent [20]. Recently, it was demonstrated that during metabolic inhibition, calcium
transients (CaTs) are decreased and AP is prolonged [6]. This reduction of CaT can result in the
slowdown of LTCCs inactivation and may be involved in the prolongation of AP in rabbit hearts [6].
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The transient increase of ICaL during ischemia may lead to early afterdepolarisation and long QT
which can be followed by arrhythmias. In our study, double exponential fit to ICaL curves showed a
significant increase of the fast component τ1 during the transient increase of ICaL in the presence of
FCCP. It is known that the fast component of ICaL inactivation is dependent on the magnitude of Ca2+
release from SR [2]. Thus, this also points to the possible connection between the transient increase
of ICaL and intracellular Ca2+ release during metabolic inhibition. In order to test the hypothesis that
the changes of Ca2+ release from SR result in the potentiation of ICaL, we have performed a series of
experiments where, prior to the application of metabolic inhibitors, SR Ca2+ release was suppressed.
Suppression of SR Ca2+ release in cardiac cells reduces CICR and therefore leads to decreased CDI of
LTCCs. Consequently, a significant augmentation of ICaL was observed in the presence of thapsigargin
or ryanodine (Figure 3 and Supplementary Figure S3). This is consistent with observations that the
elimination of the CICR-dependent CDI using thapsigargin or ryanodine, significantly prolongs AP
duration in rat ventricular myocytes [22,23]. When thapsigargin and ryanodine treated rat ventricular
myocytes were exposed to FCCP, the initial increase of ICaL was completely abolished and only
pronounced suppression of ICaL was observed. In addition, in the presence of thapsigargin, the effect
of FCCP on the ICaL inactivation fast time constant τ1 (a parameter that is greatly affected by CDI) was
eliminated. We suggest that under these conditions, CDI of ICaL is abolished and, therefore, an increase
in ICaL is not observed. For the same reason, there is a lack of ICaL facilitation in thapsigargin treated
rat cardiac cells where the decay characteristics of fast and slow components of ICaL were significantly
augmented and subsequent metabolic inhibition resulted only in a rapid decrease of ICaL without any
initial ICaL increase. The finding that CDI plays a crucial role in the initial potentiation of ICaL during
metabolic inhibition was also supported by the experiments where CDI was eliminated by equimolar
substitution of extracellular Ca2+ for Ba2+ (Figure 5). There are also evidences that mitochondria can
control the local Ca2+ level in the micro-domain near SR ryanodine receptors and play an important
role in the regulation of intracellular Ca2+ waves and arrhythmogenesis.
The double exponential fits and analysis of ISO stimulated ICaL decay traces showed that transient
ICaL increase during metabolic inhibition mimics what is observed during rapid pacing induced
facilitation of ICaL, which is well known to be related to CDI [4]. Increased frequency of stimulation
resulted in a significant augmentation of the time constant of the fast component τ1, while τ2 was
significantly diminished. Exactly the same changes in ICaL kinetics were revealed at the stimulation
phase of ICaL during metabolic inhibition. These results are consistent with Tiaho et al. (1994), where
they describe the decay phases of ICaL at the stimulation frequency of 1 Hz.
The increase in ICaL amplitude was registered not in all human cardiac myocytes and this may
point to possible impairment in cells derived from pathological cardiac specimens. However, we were
not able to find a relation between the transient increase in ICaL (or its absence) and any pathology of
the human heart. Moreover, we found that even myocytes derived from the same patient showed a
different response to metabolic inhibition, i.e., in some cardiomyocytes, the transient increase of ICaL
was registered, while in others it was not. We suggest that the observation that transient ICaL increase
is induced just in some of human atrial and ventricular myocytes while all rat ventricular myocytes
exhibit an increase in ICaL during metabolic inhibition, can be attributed to the pathophysiological
state of the particular cell as well as to differences between species. The pathophysiological state
of the cell and thus the different response to metabolic inhibition may be related with attenuation
or downregulation of β-adrenergic signaling in human heart cells [12,13]. Rat ventricular myocytes
were isolated from the healthy animals, while human cardiomyocytes were obtained from patients
of different ages and various cardiac pathologies (Supplementary Table S2). Disorganization and
degradation of T-tubule network during pathophysiological remodeling of the heart is known to
disrupt LTCC and RyR coupling [24] and to contribute to the variability of response in myocytes
isolated from the patients. In addition, it was demonstrated that even in the healthy hearts, there are
substantial differences between small rodents and large mammals in T-tubule organization and
RyR distribution, with the T-tubule network being much denser and Ca2+ release from SR more
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homogeneous in rodents’ ventricular myocytes [25]. There is also evidence that mitochondria are
involved in the control of the local Ca2+ level in the micro-domain near SR RyRs and that they play an
important role in the regulation of intracellular Ca2+ waves and arrhythmogenesis [26]. The initial
increase of ICaL shows the abnormalities of Ca2+ cycling in heart cells during ischemia (metabolic
inhibition) which may lead to the arrhythmogenic processes of the heart.
4. Materials and Methods
4.1. Isolation of Cardiomyocytes
4.1.1. Human Atrial and Ventricular Myocytes
This study was carried out in accordance with the recommendations of the principles outlined in
the Declaration of Helsinki, Kaunas Regional Bioethics Committee (Lithuania) with written informed
consent from all subjects. All subjects gave written informed consent in accordance with the Declaration
of Helsinki. The protocol was approved by the Kaunas Regional Bioethics Committee (16 November
2015 No. BE-2-40). Specimens of human heart were obtained from 16 patients undergoing heart surgery
for coronary artery diseases at the Hospital of Lithuanian University of Health Sciences (Kaunas,
Lithuania). Most of the patients had received a pharmacological treatment (including Ca2+-channel
blockers, digitalis, β-AR antagonists, diuretics, ACE inhibitors, NO-donors and/or antiarrhythmic
drugs) that was stopped 24 h before surgery. In addition, before and during surgery, all patients
received sedatives, anesthesia and antibiotics. Information on patient group and specimens is provided
in Supplementary Table S2. Dissociation of the cells was performed as described previously [27].
Briefly, the specimens of the atrial or ventricular tissue were washed in an oxygenated Ca2+ free
Tyrode solution (in mmol/L): 136 NaCl, 5.4 KCl, 1.1 MgCl2, 10 HEPES, 20 taurine, 5 sodium pyruvate,
10 D-glucose, 0.3 NaH2PO4, pH 7.3 adjusted with NaOH at room temperature. Later, the tissue was
cut into pieces of ~1 mm3 in Tyrode solution with 30 mmol/L 2,3-butanedionemonoxime added to the
solution. Subsequently, a 30–40 min incubation with collagenase (type V, 200 U/mL) and protease (type
XXIV, 5 U/mL) in 10 mL Ca2+ free BSA (5 mg/mL) containing Tyrode solution was performed at 37 ◦C.
The solution was then replaced by 10 mL of fresh solution containing collagenase (400 U/mL) and
digestion was repeated for 20–30 min. Every five minutes, a small sample of solution was examined
under a microscope to evaluate the stage of cell dissociation.
4.1.2. Rat Ventricular Myocytes
This study was carried out in accordance with the European Community guiding principles
and recommendations of the Guide for the Care and Use of Laboratory Animals of the National
Institutes of Health and UK regulations on animal experimentation [28]. The protocol was approved
by the State Food and Veterinary Service of the Republic of Lithuania (24 September 2015 No. G2-34).
Adult rat ventricular myocytes were obtained by retrograde perfusion from hearts of male Wistar rats
(160–180 g) as described previously [29]. Briefly, rats were anesthetized with intraperitoneal injection
of Pentothal and hearts were excised quickly. The hearts were retrogradely perfused at 37 ◦C with
an oxygenated Ca2+ free Ringer solution (in mmol/L): 117 NaCl, 5.8 KCl, 4.4 NaHCO3, 1.5 KH2PO4,
1.7 MgCl2, 11.7 D-glucose, 10 sodium phosphocreatine, 20 taurine, 21 HEPES, pH 7.1 adjusted with
NaOH at room temperature. For heart myocyte, dissociation collagenase type A (1 mg/mL, Boehringer
Mannheim, Germany) was added to the Ca2+ free Ringer solution and the heart was perfused for 1 h.
The ventricles were then separated from atria, cut to small pieces and agitated gently to dissociate the
single cells.
4.1.3. Electrophysiology
For electrophysiological experiments, a few drops of cells suspension were placed in a perfusion
chamber mounted on an inverted microscope stage. After cells had settled to the bottom, the chamber
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was superfused with K+ free control external solution containing (in mmol/L): 127 NaCl; 10 HEPES;
20 CsCl; 4 NaHCO3; 0.8 NaH2PO4; 1.8 MgCl2; 1.8 CaCl2; 5 D-glucose; 5 sodium pyruvate; pH 7.4
adjusted with NaOH. Patch pipettes were made from glass capillaries (Drummond, Broomall, PA,
USA) and had resistances of 0.9–1.2 MΩ when filled with control internal solution. The myocytes were
dialysed with control internal solution composed of (in mmol/L): 140 CsCl, 5 EGTA, 4 MgCl2, 0.062
CaCl2, 5 creatine phosphate disodium salt, 3.1 Na2ATP, 0.42 Na2GTP and 10 HEPES; pH to 7.3 was
adjusted with CsOH. The whole-cell patch–clamp technique was used to record the ICaL in human and
rat cardiac myocytes as described previously [30]. Ionic currents through LTCCs were registered every
8 s. ICaL facilitation was generated after 20 s of rest applying four depolarizing pulses from −80 mV
holding potential to 0 mV for 200 ms (frequency 1 Hz). Tetrodotoxin (30 µmol/L, Latoxan, Rosans,
France) and a 50 ms prepulse to −50 mV before every depolarizing pulse were used to eliminate
sodium currents. Inward peak currents were measured as the difference between the maximal inward
current amplitude and the current at the end of the test pulse [27].
Equilibrium for steady-state frequency-dependent facilitation of ICaL is reached after four
stimulations [31], therefore ICaL facilitation was assessed comparing the first ICaL trace with the
fourth trace at 1 Hz. The peak of ICaL and the ICaL area, an integral of ICaL for 200 ms (pA x ms), were
registered at the time of the first and fourth depolarizing pulse. The time integral of ICaL was registered
in part of the experiments to elucidate the origin of ICaL increase during metabolic inhibition and to
compare the initial effect of FCCP with frequency-dependent facilitation and reduced CDI.
To determine the current–voltage (I–V) relationship and inactivation of ICaL, a double pulse
voltage-clamp protocol was applied every 4 s (see insert in Figure 2c). During the first pulse S1,
the membrane potential was set at membrane potentials ranging from −100 to +100 mV for 200 ms.
S1 pulse was followed by a 3 ms repolarization to the−80 mV holding potential and then a depolarizing
pulse S2 to 0 mV was applied for 200 ms.
All experiments were performed at room temperature (18–24 ◦C) and the temperature did not
change by more than 1◦C during an experiment.
4.1.4. Chemicals and Stock Solutions
All drugs and chemicals were from Sigma-Aldrich (Schnelldorf, Germany) if not specified
otherwise. All drugs tested in patch-clamp experiments were solubilized in experimental solutions
just before application onto the cell studied, i.e., only fresh solutions were tested. To block oxidative
phosphorylation stock solutions of carbonyl cyanide-p-trifluoromethoxyphenylhydrazone (FCCP,
100 µmol/L), 2,4-Dinitrophenol (DNP, 100 mmol/L) in ethanol, rotenone (100 mmol/L) and antimycin
A (100 mmol/L) in DMSO were used. The stock solution of the SR Ca2+ ATP-ase inhibitor thapsigargin
(10 mmol/L) was prepared in ethanol. A stock solution of ryanodine (10 mmol/L) for blocking of
RyR channels was prepared in distilled water. An aqueous stock solution of the isoprenaline (ISO,
1 mmol/L) was freshly prepared every day prior to the experiments. When the stock solutions in
DMSO or ethanol were used, the corresponding amount of solvent was also added to the external
control solution.
4.1.5. Data Analysis
Inactivation of ICaL traces were best fitted by the sum of two sequential exponentials using
the expression:
I(t) = ICaL,1 × exp(−t/τ1) + ICaL,2 × exp(−t/τ2), (1)
where I is the current at time t; ICaL,1 and ICaL,2 are the amplitudes and τ1 and τ2 are the time constants
of the fast and slow components of ICaL, respectively. The fitting of ICaL inactivation traces was
performed using the modified protocol described by [32] in rat ventricular myocytes.
The fitting time was set from ~1 ms after the peak of inward calcium current until the end of
400 ms pulse. The steady-state current was calculated at the end of 400 ms pulse and this helped to
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avoid residual leak current influence to the inactivation of ICaL. The quality of the fits were evaluated
by correlation coefficients (r) and in all of the experiments, the correlation coefficient was ≥0.985.
Steady-state inactivation curves (B1) and I–V traces (B2) were fitted with Boltzmann equations:
B1(V) = 1/(1 + exp((V1/2 − V)/k); (2)
B2(V) = g(V − Vrev)/(1 + exp((V1/2 − V)/k), (3)
where V1/2 is 0.5 of the maximal value of steady-state activation and inactivation, Vrev is the reversal
potential of Ca2+, g is the conductance of LTCC and k is the steepness parameter.
Data is expressed as the means ± standard errors of the mean (SEM). The significance of
differences was evaluated using one-way analysis of variance (ANOVA). The significance level was
set at p < 0.05. In the text, the “basal ICaL” refers to the Ca2+ current which was not stimulated by
β-adrenergic agonist.
5. Conclusions
In conclusion, our data demonstrate that metabolic inhibition in mammalian cardiomyocytes
causes an initial stimulation of ICaL which is due to a reduction in SR function and an alleviation of the
Ca2+-dependent inactivation of the L-type Ca2+ channels. These mechanisms may contribute to the
formation of arrhythmias in the ischemic heart and may be targets for new treatment methods of heart
pathologies in the future.
Supplementary Materials: Supplementary materials can be found at http://www.mdpi.com/1422-0067/20/6/
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